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Abstract
Normal  pressure  hydrocephalus  is  characterised  by  the  triad  of  gait  disturbance,
dementia and urinary incontinence. Although our understanding of the condition has
considerably improved since it was initially described over 50 years ago, its patho‐
physiology is still a matter of debate. We provide an overview of the current concepts
in pathophysiology and discuss the clinical features, diagnosis and treatment of this
cause of dementia.
Keywords: cerebrospinal fluid, cerebral blood flow, vascular compliance, CSF outflow
resistance, neurodegeneration
1. Introduction
First described by Hakim and Adams [1] in 1965, normal pressure hydrocephalus (NPH) is a
potentially reversible cause of dementia. It is a communicating hydrocephalus, which occurs
as a result of impaired re‐absorption of cerebrospinal fluid (CSF). This can be caused by a
number of conditions including meningitis, trauma and subarachnoid haemorrhage. Howev‐
er, in a large number of cases, it is idiopathic (INPH). INPH is characterised clinically by the
triad of gait disturbance, cognitive decline and urinary incontinence. Ventriculomegaly is
observed on magnetic resonance imaging (MRI) or computed tomography (CT). However, the
symptoms of INPH are non‐specific and can occur in other conditions. Moreover, the classic
triad is not always present. Varying combinations and degrees of each element of the triad are
encountered in different patients and depending on the stage of the condition. INPH has an
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insidious onset and progresses gradually. Shunt surgery results in a positive response in as
many  as  84%  in  a  European  multicentre  study  [2].  Although  the  treatment  is  surgical,
neurological input is important for the diagnosis and identification of suitable shunt candi‐
dates. In some countries, hydrocephalus is a purely surgical condition. However, like several
authors, we believe that a multidisciplinary approach is essential for the optimal manage‐
ment of these patients. In our neuroscience centre, the management of INPH involves the
neurologists, neurosurgeons and physiotherapists.
2. Methods
This review was prompted by the large number of publications on INPH. We searched the
databases of Medline, Embase and the Cochrane Library for articles relating to INPH up to
February 2016. We included review articles and research studies according to their relevance.
3. Epidemiology
It is difficult to accurately establish the incidence and prevalence of INPH because several cases
are likely to be undiagnosed due to the non‐specific nature of the symptoms. However, it is
clear from epidemiological studies that the incidence increases with age. Tisell et al. [3]
observed that one to two shunt operations per 100,000 inhabitants were being performed
yearly for INPH. Brean and Eide [4] found that the prevalence was up to 181.7 per 100,000
people in the 70–79 years age group in Norway [4]. After randomly subjecting 497 individuals
over the age of 65 to magnetic resonance imaging (MRI) of the brain, Tanaka et al. found a
prevalence of 1.4% in that age group [5]. It is also estimated that up to 10% of patients with
dementia may have INPH [6].
4. Pathophysiology
The CSF space is a dynamic pressure system. It is responsive to changes in CSF formation or
reabsorption rates, arterial and venous flow, compliance of the intracranial structures and
fluctuations in intracranial pressure (ICP). Around 500 ml of CSF is produced every day and
the total volume of CSF at any one point is between 120 and 150 ml. The brain is unique in the
sense that it is the only organ enclosed in a non‐expansile box (i.e. the skull). According to the
Monro‐Kellie hypothesis, the total volume of the constituents in the cranium is fixed. There‐
fore, an increase in the volume of any of the constituents has to be matched by a decrease in
the volume of another to avoid an increase in intracranial pressure. The volume of blood
entering the brain varies with the cardiac cycle. There is a net intracranial inflow of blood
during systole and a net outflow during diastole. Arterial supply to the brain is pulsatile
whereas venous flow is less so, and this mismatch causes transient rises in pressure. The brain
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and other intracranial constituents can compensate for this in two ways. Firstly, the blood
vessels have a degree of compliance which allows for a smoother influx of arterial blood.
Secondly, CSF flows back and forth through the cerebral aqueduct in response to pulsatile
blood flow, thereby maintaining intracranial pressure stable. However, in INPH, the intracra‐
nial constituents become less compliant [7]. A reduction in vascular compliance especially in
the superior sagittal sinus has been found [8]. This can initially be countered by increased
pulsatile CSF flow through the aqueduct. If this fails, the amplitude of arterial pulsatility
increases during systole inducing large ICP pulsations (‘water hammer’ effect). These pulsa‐
tions, in addition to causing venous damage in the periventricular region, displace the brain
towards the skull [9]. Hydrocephalus occurs as a result of enlarging ventricles at the expense
of a reduced subarachnoid space. This is secondary to increasing pressure within the ventricles
directed towards the subarachnoid space. The pressure gradient arising between the ventricles
and the subarachnoid space is termed ‘transmantle pressure’. The transmantle pressure
gradient has to be the only force which could cause such changes to the brain [9]. CSF spaces
revert to normal following shunting, implying that the transmantle pressure gradient can be
reduced or reversed. This pressure gradient also explains why, although there is increased
intraventricular pressure, the measured opening pressure during a lumbar puncture is within
normal limits. It also implies that ‘normal pressure’ in NPH is somewhat of a misnomer.
What triggers the initial reduction in compliance that results in INPH? Most theories on INPH
attempt to explain the pathophysiology around the finding of reduced cerebral blood flow
(CBF). There is a strong association between impaired CBF and INPH. Patients with INPH are
more likely to have concomitant cerebrovascular disease [10]. MRI shows increased white
matter changes (WMCs) [11] and this is further supported by neuropathological studies
showing microvascular infarctions but also interstitial oedema, ependymal disruption, gliosis
and neuronal degeneration [12, 13]. In addition, there is an association between high ICP and
impaired cerebrovascular autoregulation [14]. Age‐related atherosclerosis has been proposed
as being responsible for the reduction in vascular compliance [15]. This would explain the
association between NPH and vascular disease (VD). Bateman [8], on the other hand, proposes
that increased transvenular resistance in the territory of the superior sagittal sinus is the
initiating event in NPH. While some consider that CSF resorption occurs at the level of the
arachnoid villi or arachnoid granulations, others believe that the majority of CSF resorption
occurs through brain parenchyma at the levels of capillaries and veins [9, 16–18]. If the latter
hypothesis is true, CSF resorption would be affected with increased transvenular resistance.
Indeed, CSF resorption is unequivocally abnormal in INPH [19]. CSF outflow resistance or
conductance (which is inversely proportional to resistance) has been investigated in a few
studies [20–22] and found to be impaired. Early studies in animals and humans suggest that,
in the initial stages, mounting CSF intraventricular pressure secondary to abnormal CSF flow
causes ventricular dilatation [8]. It is therefore possible that CSF outflow disturbance, occurring
secondary to reduced venous compliance, is directly related to the ventriculomegaly seen in
INPH.
But why would venous resistance increase in an elderly patient? Bradley believes that deep
white matter ischaemia is the triggering event [23]. Due to ischaemia, surrounding arterioles
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are already maximally dilated, and this would explain the loss of autoregulation [23]. When
the arterioles are obstructed, venous collapse ensues, followed by impaired CSF drainage and
ventricular enlargement [23]. The problem we have with this hypothesis is that if one wants a
unifying theory with ischaemia as the initiating trigger, one would struggle to explain the
appearance of NPH in disorders such as progressive supranuclear palsy (PSP), corticobasal
degeneration (CBD) and Alzheimer's disease (AD). Periventricular white matter ischaemia is
an uncommon finding especially in PSP and CBD. Yet, there has to be a final common pathway
which results in hydrocephalus in all these conditions. We hypothesise that neurodegeneration
has a role to play in INPH, at least in some cases. The following findings would support this:
• Of the 38 patients in two studies who were diagnosed with INPH, vascular changes (71%),
AD (61%), PSP (2.6%) and CBD (2.6%) were the most frequent co‐existing pathologies and
none had specific neuropathological changes to suggest INPH as an entity [24, 25].
• Levels of tau protein in CSF, an index of neuronal degeneration, were found to be higher in
patients with NPH compared to healthy controls [26] although phospho‐tau181 was lower
in INPH than in those with established AD [27].
• Midbrain atrophy is strongly associated with gait disturbance in NPH [28].
• Although the gait disturbance improves with shunting, the dementia seen in INPH often
does not and it continues to progress, suggesting a difference in the aetiopathogenesis
underlying these symptoms.
• Even if there is an initial response, overall the condition eventually progresses despite a
functioning shunt in situ in the majority of cases. It is therefore possible that those who
deteriorate quicker also have more rapid neurodegeneration (e.g. PSP) than those who
deteriorate less rapidly (e.g. AD).
Finally, we take the opportunity to emphasise the possibility that INPH has different causes
which form a pathophysiological continuum. This would not only explain the differences with
shunt response and rates of progression but would also explain why a universal theory remains
elusive. It would perhaps be more appropriate to refer to these conditions, where known, as
VD‐associated NPH, AD‐associated NPH, etc.
5. Clinical features
5.1. Gait disturbance
Gait disturbance is usually the commonest and earliest symptom of INPH. Its onset is insidious
over months and sometimes years. It is also the one that is most likely to respond to shunting.
The gait impairment in NPH is frequently described as ‘apraxic’. Other descriptors used are
‘shuffling’, ‘magnetic’ and ‘broad‐based’. Thompson [29] is in favour of the term ‘frontal lobe
ataxia’ instead of gait apraxia, which is defined as an impairment of gait not attributed to motor
or sensory deficits, although he acknowledges that this is based on observation rather than on
firm evidence for this. Interestingly, some patients display normal ability to move the legs in
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a recumbent position while being practically unable to walk. This phenomenon indicates that
the gait disturbance is due to a problem with locomotion rather than a pure motor dysfunction.
There is no single feature that is pathognomonic of the gait disturbance in NPH. In mild cases,
patients may display a broad‐based gait but in more severe cases there is a reduction in stride
length [30]. The feet appear clumsy and there is difficulty initiating foot movements. Patients
are also slow to rise from a seated position. The gait is also characterised by reduced step height
and a typical disturbance of the dynamic equilibrium [31]. About 30% of patients experience
freezing of gait [31]. Patients tend to turn in multiple small steps. Postural instability and falls
are common. The gait pattern in INPH is visibly different from that of Parkinson's disease [31].
A wider step, as well as increased foot angles, is uncharacteristic of Parkinson's disease but
common in INPH. Upper limb movements are preserved. The reason is that the motor fibres
controlling the upper extremities and face originate more laterally in the motor cortex and are
subsequently subjected to less stretching due to hydrocephalus [32]. Upper motor neuron
signs, such as spasticity and hyperreflexia, are unusual. Since the symptoms of INPH are
symmetrical, any lateralising signs should raise suspicion of other disorders.
5.2. Dementia
The cognitive deficits in INPH are classically that of a subcortical dementia with predomi‐
nantly frontal features [33–35] and are characterised by apathy, inattention, psychomotor
retardation and poor executive function [36]. It is worth noting that the term ‘dementia’ is used
to designate the cognitive impairment in INPH although some patients who present early may
not have evidence of this or may not meet the criteria for dementia on cognitive testing. Saito
et al. have shown that the deficits extend beyond executive function, attention and memory to
visuoperceptual and visuospatial domains on neuropsychological testing [37]. There is
substantial overlap between INPH and AD but frontal lobe dysfunction account for >50% of
the cognitive deficit in INPH while memory impairment is responsible for >50% of the
cognitive deficit in AD [37]. The degree of neuropsychological impairment in INPH has also
been found to relate to the severity of other signs of INPH [38]. Those with vascular risk factors
performed worse than those without [38]. Compared with Binswanger's disease, impairment
of memory and visuospatial attention in NPH may be more pronounced [39].
5.3. Urinary incontinence
Urinary incontinence is often the last symptom to appear, although it is well established that
each symptom can occur independently of the others [40]. Increased urinary urgency occurs
earlier and is almost always present in INPH [40, 41]. Urinary incontinence is also very
common in the elderly and therefore, on its own, lacks specificity. Fisher [40] considered it to
be a frontal lobe incontinence as patients were indifferent regarding where and when to
urinate. This correlates with the pattern of cognitive deficits mentioned earlier. Sakakibara et
al. [42] have found that detrusor overactivity, seen in 95% of their cases, is fundamental to the
appearance of urinary urgency, frequency and incontinence. Seventy‐one per cent had voiding
symptoms such as difficulties in initiating urination and poor flow [42]. Bladder dysfunction
can improve after shunting suggesting that the symptoms are likely secondary to impaired
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cerebral control of bladder storage. The underlying mechanism for detrusor overactivity in
patients with NPH appears to be related to reduced cerebral blood flow in the right frontal
cortex, and to a lesser extent impaired basal ganglia function [43]. Reduced mobility could also
be contributing to incontinence in these patients [43].
6. Investigations
6.1. Neuroimaging
The diagnosis of INPH in the right clinical context relies on the finding of hydrocephalus on
brain imaging (Figure 1A). Hydrocephalus is not synonymous with ventriculomegaly.
Although ventriculomegaly is commonly found in the elderly population, this does not imply
the presence of NPH. In NPH, the ventriculomegaly is typically out of proportion to the
amount of atrophy present. CT of the brain is a sensitive imaging modality to identify NPH
but MRI provides additional information such as aqueductal stenosis, white matter changes
or the presence of an underlying aetiology (e.g. AD). A coronal section reveals a narrow
subarachnoid space surrounding the outer surface of the brain (hence the term ‘tight convex‐
ity’) and narrow medial cisterns. The cortical sulci at the vertex are effaced (Figure 1B), whereas
the temporal horns are widened (Figure 2A). The third ventricle is often enlarged, whereas
the fourth ventricle can be either dilated or normal. Therefore, a normal‐sized fourth ventricle
in the presence of enlarged lateral and third ventricles does not necessarily suggest aqueductal
stenosis and is a finding consistent with NPH. Other imaging features of NPH are discussed
below.
Figure 1. Ventriculomegaly and effacement of sulci at the vertex in a patient with INPH (A and B), with some post‐
operative improvement (C and D).
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Figure 2. (A) Dilated Sylvian fissures and temporal horns. (B) Periventricular white matter hyperintensities on MRI.
(C) Isolated dilated sulci.
6.1.1. Evan's index
An objective way of assessing whether the ventricles are enlarged is through the use of Evan's
index. It is the ratio of the maximum width of the frontal horns of the lateral ventricles and the
transverse inner diameter of the skull, measured at the same level on both axial CT and MRI
images [44, 45]. A value above 0.30 is considered significant, although in our own experience,
the higher the value, the more specific it is for NPH. Unfortunately, Evan's index is a crude
marker of hydrocephalus and varies significantly depending on the location and angle of the
slice [46]. It is therefore of limited value on its own.
6.1.2. Callosal angle
The concept of callosal angle with respect to NPH was first described on pneumoencephalo‐
gram by Benson et al. [47] and thereafter by Sjaastand and Nordvik [48]. The International
guidelines mention an angle of greater than 40° as supportive of NPH [49]. However, using
MRI, Ishii et al. [50] found that a callosal angle of less than 90°, measured on a coronal plane,
which is perpendicular to the AC–PC plane on the posterior commissure plane, helped in
differentiating INPH patients from AD and normally aged subjects. The narrow angle is caused
by the elevation of dilated ventricles and compression due to dilated Sylvian fissures
(Figure 2A). When combined with Evan's index of >0.3, INPH could be discriminated from
AD with a sensitivity and specificity of 97 and 94%, respectively [50].
6.1.3. White matter changes (WMC)
INPH is known to be associated with deep white matter changes (DWMC) and smooth
periventricular hyperintensity (PVH) [51] on MRI (Figure 2B). As discussed earlier, there is an
element of cerebral hypoperfusion in INPH which is thought to contribute to the development
of INPH. It is, however, unclear whether the WMC are cause or effect. Regardless of the
underlying pathophysiological mechanisms implicated in NPH, there is consistent neuropa‐
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thological evidence demonstrating the involvement of white matter. A diversity of patholog‐
ical observations, such as direct mechanical compression of the periventricular white matter,
ischaemic demyelination and infarction, have been noted in INPH [12, 13, 52]. Indeed, DWMC
and subcortical infarctions are commonly seen in patients with Binswanger's disease, and these
patients often have similar symptoms to those with INPH. Tullberg et al. [51] evaluated the
diagnostic features of DWMC and PVH using MRI, and found that no MRI variable could
reliably differentiate NPH from BD. One explanation for this result, put forward by the authors,
is that NPH and BD are two disorders with similar pathophysiological mechanisms or that
they form a pathophysiological continuum of increasing microangiopathy [51].
6.1.4. CSF flow void
As mentioned earlier, CSF flows back and forth the aqueduct during the cardiac cycle in
response to arterial blood flow to the brain. This was initially observed as a flow void,
consisting of a decreased MRI signal, mainly in the aqueduct on T2‐weighted images of early
MR scans in patients with communicating hydrocephalus [53–55]. CSF flow void can be
observed in normal individuals, but it is more prominent in INPH [56]. Increased aqueductal
CSF flow initially appeared to be predictive of a good response with shunting [55, 57, 58], but
further studies have found poor correlation between the extent of CSF flow void and surgical
outcome [56, 59].
6.2. CSF tap test
Patients with suspected INPH, based on clinical features and neuroimaging, should undergo
a high‐volume CSF tap to predict response with shunting. The rationale for a CSF tap is that
it simulates the physiological effect of a shunt [45]. The patient is assessed pre‐ and post‐CSF
tap for gait and cognitive improvements. About 40–50 ml of CSF is usually removed. Gait is
most likely to ameliorate following CSF tap; therefore, it is the best indicator of response. In
our centre, we use the 10‐m timed‐walk test and Tinetti test to assess gait and balance before
and after CSF removal. Our patients are also consented for video recordings as these can be
useful to retrospectively assess patients especially when the improvement following CSF tap
is not clear. It is common that some patients or their carers only notice an improvement a couple
of days down the line. We therefore carry out follow‐up telephone assessments in all our
patients 3 days after they have undergone a CSF tap. This is quite a subjective measure for
improvement. Nevertheless, it reduces the chances of missing potentially suitable candidates
for shunt surgery. Unfortunately, although the CSF tap test has a high positive‐predictive value
for shunt success, it has a low sensitivity [60] and should not be used to exclude patients from
shunt surgery. There are patients who do respond to shunt surgery after a negative tap test.
The first edition of the Japanese guidelines advocated repeating the tap test if initially negative
[61], but the more recent edition suggests that further investigation may be required [62].
Recently, Yamada et al. have shown that the timing of the CSF tap affects the accuracy of the
test [63]. It should be carried out as soon as symptoms appear [63]. An external lumbar drain,
which provides continuous drainage, has a similar predictive value to the CSF tap test, a higher
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sensitivity [64, 65], but a low negative-predictive value. It is important to note that this test is
more invasive, and can give rise to complications such as radicular pain and meningitis.
7. Diagnostic guidelines
Different centres use different criteria for diagnosing INPH and recommending shunt surgery.
The decision to shunt a patient with predominantly gait disturbance, typical imaging features
and a positive CSF tap test is straightforward. However, the difficulty arises when patients do
not show characteristic clinical features or do not show a definite improvement to CSF removal.
The purpose of diagnostic guidelines in INPH is to identify those patients who are most likely
to benefit from shunt surgery. Recently, the American Academy of Neurology has published
its own practice guidelines [66]. However, the international [49] and Japanese [62] guidelines
are probably the two most widely used and will be given further consideration in this chapter.
Both have some similarities but also a few notable differences. The terms ‘possible’ and
Features International guidelines Japanese guidelines
Size of
ventricles
Ventricular enlargement not entirely attributable to cerebral
atrophy or congenital hydrocephalus (Evan's ratio >0.3 or
equivalent)
Evan's ratio >0.3
Addition‐
al imaging
features
No obvious obstruction to CSF flow Dilated subarachnoid spaces in the Sylvian
fissures and narrowed spaces over the high
cerebral convexity and medial surface (DESH)
And at least one of the following: One or more elliptically dilated sulci over the
medial surface and convexity in isolation*
(Figure 2C)
  1. Enlargement of temporal horns not solely
     due to hippocampal atrophy
A callosal angle of less than 90° on coronal
section perpendicular to the anterior commis‐
sure‐posterior commissure plane*
  2. Callosal angle of 40° or more
  3. Evidence of altered brain water content,
     including periventricular signal changes on CT and
     MRI not attributable to microvascular ischemic
     changes or demyelination
  4. An aqueductal or fourth ventricular flow void on
     MRI
DESH = disproportionately enlarged subarachnoid space hydrocephalus.
*These features are supportive but not essential for a diagnosis of possible INPH.
Table 1. Imaging features of INPH: comparing the international and Japanese guidelines.
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‘probable’ INPH are employed in each, with diagnostic criteria based on clinical and imaging
features. However, the Japanese guidelines use the term ‘probable INPH’ in those who
improve following the removal of CSF. They also label those who respond to shunt surgery as
having ‘definite’ INPH. The international guidelines make no mention of response to CSF
removal or shunting in their diagnostic criteria. The neuroimaging criteria also differ. Table 1
shows a comparison of the diagnostic neuroimaging features used in these guidelines.
8. Predictors of shunt efficacy
Apart from imaging findings and CSF tap test, there are other variables that can influence
outcome after shunt surgery. Knowledge of these factors is important, and, when used in
conjunction with diagnostic guidelines, can add weight to the decision‐making process.
Several factors have been associated with either good or poor outcomes. These are summarised
in Table 2.
The presence of white matter changes is of unclear significance in predicting outcome. The
absence of white matter and severe periventricular signals on T2‐weighted imaging studies
was associated with a good response to shunt placement [71]. The degree of periventricular
and deep white matter lesions was shown to be inversely correlated with the degree of clinical
improvement in 41 patients [72]. However, as mentioned earlier, Tullberg et al. [51] found that
conventional MRI could not reliably differentiate between the causes of white matter changes
and that the presence of DWMH or subcortical lacunar infarctions in NPH did not predict a
poor outcome from shunt surgery [11]. These patients should not be denied surgery on the
basis of these findings alone [11].
Features Favourable
outcome
Poor
outcome
Clinical Gait disturbance occurring before cognitive impairment Dementia as the initial neurological
sign
Mild or moderate dementia Severe dementia at presentation
Shorter duration of symptoms Dementia for more than 2 years [67,
68]
CSF measures CSF outflow resistance of 18 mm Hg/ml/min or higher
during lumbar constant flow infusion (boon 1998)
Occurrence of B‐waves during 50% or more of the
recording time during continuous ICP monitoring
Pathological
markers
AD pathology on cortical biopsy [69,
70]
Table 2. Factors influencing the outcome of shunt surgery.
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9. Shunt surgery
Surgical diversion of CSF via a shunt is the standard intervention for INPH. This is based
on the presumption that CSF diversion will reduce or normalise the transmantle pres‐
sure, thereby stabilising or improving symptoms. Ventriculoperitoneal shunts are most
commonly used [73]. It is important to remember that not every patient with possible or
probable INPH will be a candidate for shunt surgery. The risk‐to‐benefit ratio has to be
assessed individually. The patient or family should understand that dementia is least
likely to improve and that the mean chance of significant improvement is 30–50% [44].
Information about the risks of complications should also be explicit.  Initial studies of
shunting in INPH reported a low rate of significant long‐term improvement, but a high
rate of complications [74]. There is no definite consensus on how to best assess re‐
sponse to shunting. Also, there was no randomised control trial comparing the out‐
comes of shunting until 2011. This was a small study involving 14 patients who were
randomised to open or closed shunts [75]. Those who initially had their shunts ligated
after surgery had their shunts opened after 3 months. Those with open shunts experi‐
enced an improvement in motor and psychometric scores (30 and 23% increase, respec‐
tively) at 3 months, whereas those with ligated shunts were unchanged. This group,
however, improved following opening of the shunts at 3 months, with an increase in
motor and psychometric scores of 28 and 18%, respectively. A systematic review conclud‐
ed that long‐term response was 29% [76]. However, results of more recent studies show
a significantly higher rate of 80–90% [2, 77]. It is clear that a general consensus is required
to standardise the measurement of outcomes following shunting.
9.1. Complications
In their systematic review, Hebb et al. [76] also found a mean complication rate of 38%.
Potential complications include infection, seizures, abdominal problems (peritonitis, perfora‐
tion, volvulus and ascites), shunt failure or blockage, shunt over‐drainage and intracranial
haemorrhage. Shunt over‐drainage is the commonest complication in the first year occurring
in about one‐third of patients [76, 78]. Complication rates can differ between centres. The Eu‐
iNPH study revealed a complication rate of 28% [2], while Poca et al. [77] found a complication
rate of less than 12% in a prospective study involving 236 patients.
9.2. Follow‐up
Follow‐up after surgery helps to identify patients who are unchanged or worse, and those who
can be helped by further adjustments or shunt revision. Repeat brain imaging is routinely
undertaken in the immediate aftermath of surgery, but when performed further down the line,
it can also identify a subdural haemorrhage in those who are over‐drained. If this is the case,
a higher opening pressure should be targeted. Conversely, a retrospective study found that in
those with no substantial improvement and in whom under‐drainage is suspected, selecting
a lower pressure can improve the outcome [79].
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10. Conclusions
INPH is probably more common that we realise. Due to its reversibility, it is imperative that
not only neurologists but other physicians, in particular geriatricians, are more aware of this
condition. Although significant progress has been made in our understanding of this condi‐
tion, a unifying theory explaining its pathophysiology is still awaited. Numerous pathophy‐
siological changes have been noted, but it remains unclear which is the cause, effect or
epiphenomenon. Given that patients with INPH have pathologies such as VD, AD and PSP,
among others, we therefore regard INPH as a multi‐aetiological disorder. For similar reasons,
we feel that the role of neurodegeneration should be explored further. Treatment with shunting
remains the gold standard. Unfortunately, too often, the condition eventually progresses.
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